Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

CAR T-cell therapies have demonstrated efficacy in treating blood cancers but, so far, their safety and effectiveness in ...

The single-cell landscape of small cell neuroendocrine cervical carcinoma revealed the tumor heterogeneity and the molecular subtypes, laying the foundation for exploring tumor etiology ...

Almost all cases are caused by human papillomavirus (HPV) infection, with approximately 80% classified as squamous cell carcinoma (SCC); the remainder are largely adenocarcinomas. Cervical cancer ...

The theme for World Cancer Day 2025 is ‘United by Unique’. This theme emphasises a people-centred approach to cancer care, ...

The single-cell landscape of small cell neuroendocrine cervical carcinoma revealed the tumor heterogeneity and the molecular subtypes, laying the foundation for exploring tumor etiology ...

Share and Cite: Hinz, B. and Kenyon, J. (2025) Getting to a Diagnosis: A Rare Case of TFE3 Translocation Renal Cell Carcinoma ...

Q4 2024 Earnings Call Transcript February 4, 2025 Merck & Co., Inc. misses on earnings expectations. Reported EPS is $1.72 ...

Initiation of Phase 1/2 combination trial with PYX-201, an extracellular ADC targeting Extradomain-B Fibronectin (EDB+FN) and Merck’s KEYTRUDA® ...

H.C. Wainwright analyst Andres Y. Maldonado confirmed a Buy rating and a $75.00 price target on Corbus Pharmaceuticals (NASDAQ:CRBP), representing significant upside potential from the current price ...

Cancer remains a major health challenge in India, ranking as the third leading cause of death after infectious and ...

The International Federation of Gynecology and Obstetrics (FIGO) staging systems for vulva, cervix, endometrium, and sarcomas have been revised for the first time in over a decade. The purpose of ...